|
1.
|
Hayashi N, Ito I, Yanagisawa A, Kato Y,
Nakamori S, Imaoka S, Watanabe H, Ogawa M and Nakamura Y: Genetic
diagnosis of lymph-node metastasis in colorectal cancer. Lancet.
345:1257–1259. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
O’Sullivan GC, Collins JK, Kelly J, Morgan
J, Madden M and Shanahan F: Micrometastases: marker of metastatic
potential or evidence of residual disease? Gut. 40:512–515.
1997.PubMed/NCBI
|
|
3.
|
Mori M, Mimori K, Ueo H, Tsuji K,
Shiraishi T, Barnard GF, Sugimachi K and Akiyoshi T: Clinical
significance of molecular detection of carcinoma cells in lymph
nodes and peripheral blood by reverse transcription-polymerase
chain reaction in patients with gastrointestinal and breast
carcinomas. J Clin Oncol. 16:128–132. 1998.
|
|
4.
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cristofanilli M, Hayes DF, Budd GT, Ellis
MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC,
Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor
cells: a novel prognostic factor for newly diagnosed meta-static
breast cancer. J Clin Oncol. 23:1420–1430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Funaki NO, Tanaka J, Ohshio G, Onodera H,
Maetani S and Imamura M: Cytokeratin 20 mRNA in peripheral venous
blood of colorectal carcinoma patients. Br J Cancer. 77:1327–1332.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Taniguchi T, Makino M, Suzuki K and
Kaibara N: Prognostic significance of reverse
transcription-polymerase chain reaction measurement of
carcinoembryonic antigen mRNA in tumor drainage blood and
peripheral blood of patients with colorectal carcinoma. Cancer.
89:970–976. 2000. View Article : Google Scholar
|
|
8.
|
Guadagni F, Kantor J, Aloe S, Carone MD,
Spila A, D’Alessandro R, Abbolito MR, Cosimelli M, Graziano F,
Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri
SV, Steinberg SM, Roselli M and Schlom J: Detection of blood-borne
cells in colorectal cancer patients by nested reverse
transcription-polymerase chain reaction for carcinoembryonic
antigen messenger RNA: longitudinal analyses and demonstration of
its potential importance as an adjunct to multiple serum markers.
Cancer Res. 61:2523–2532. 2001.
|
|
9.
|
Sadahiro S, Suzuki T, Tokunaga N, Yurimoto
S, Yasuda S, Tajima T, Makuuchi H, Murayama C and Matsuda K:
Detection of tumor cells in the portal and peripheral blood of
patients with colorectal carcinoma using competitive reverse
transcription-polymerase chain reaction. Cancer. 92:1251–1258.
2001. View Article : Google Scholar
|
|
10.
|
Tsavellas G, Patel H and Allen-Mersh TG:
Detection and clinical significance of occult tumour cells in
colorectal cancer (Review). Br J Surg. 88:1307–1320. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Conzelmann M, Linnemann U and Berger MR:
Detection of disseminated tumour cells in the liver of cancer
patients. Eur J Surg Oncol. 31:977–985. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Iddings D, Ahmad A, Elashoff D and Bilchik
A: The prognostic effect of micrometastases in previously staged
lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann
Surg Oncol. 13:1386–1392. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Doekhie FS, Kuppen PJ, Peeters KCMJ,
Mesker WE, van Soest RA, Morreau H, van de Velde CJ, Tanke HJ and
Tollenaar RA: Prognostic relevance of occult tumor cells in lymph
nodes in colorectal cancer. Eur J Surg Oncol. 32:253–258. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Riethdorf S, Wikman H and Pantel K:
Biological relevance of disseminated tumor cells in cancer patients
(Review). Int J Cancer. 123:1991–2006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Katsuno H, Zacharakis E, Aziz O, Rao C,
Deeba S, Paraskeva P, Ziprin P, Athanasiou T and Darzi A: Does the
presence of circulating tumor cells in the venous drainage of
curative colorectal cancer resections determine prognosis? A
meta-analysis. Ann Surg Oncol. 15:3083–3091. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Rosenberg R, Hoos A, Mueller J, Baier P,
Stricker D, Werner M, Nekarda H and Siewert JR: Prognostic
significance of cytokeratin-20 reverse transcription-polymerase
chain reaction in lymph nodes of node-negative colorectal cancer
patients. J Clin Oncol. 20:1049–1055. 2002. View Article : Google Scholar
|
|
17.
|
Choi HJ, Choi YY and Hong SH: Incidence
and prognostic implications of isolated tumor cells in lymph nodes
from patients with Dukes B colorectal carcinoma. Dis Colon Rectum.
45:750–755. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Noura S, Yamamoto H and Ohnishi T:
Comparative detection of lymph node micrometastases of stage II
colorectal cancer by reverse transcription-polymerase chain
reaction and immunohistochemistry. J Clin Oncol. 20:4232–4241.
2002. View Article : Google Scholar
|
|
19.
|
Merrie AE, van Rij AM, Dennett ER,
Phillips LV, Yun K and McCall JL: Prognostic significance of occult
metastases in colon cancer. Dis Colon Rectum. 46:221–231. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Shimoyama M, Yamazaki T, Suda T and
Hatakeyama K: Prognostic significance of lateral lymph node
micrometastases in lower rectal cancer: an immunohistochemical
study with CAM5.2. Dis Colon Rectum. 46:333–339. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Palma RT, Waisberg J, Bromberg SH, Simão
AB and Godoy AC: Micrometastasis in regional lymph nodes of
extirpated colorectal carcinoma: immunohistochemical study using
anti-cytokeratin antibodies AE1/AE3. Colorectal Dis. 5:164–168.
2003. View Article : Google Scholar
|
|
22.
|
Fisher ER, Colangelo L, Wieand S, Fisher B
and Wolmark N: Lack of influence of cytokeratin-positive
mini-micrometastases in ‘Negative Node’ patients with colorectal
cancer: findings from the National Surgical Adjuvant Breast and
Bowel Projects protocols R-01 and C-01. Dis Colon Rectum.
46:1021–1025. 2003.PubMed/NCBI
|
|
23.
|
Bukholm IR, Bondi J, Wiik P, Nesland JM,
Andersen SN, Bakka A and Bukholm G: Presence of isolated tumour
cells in mesenteric lymph nodes predicts poor prognosis in patients
with stage II colon cancer. Eur J Surg Oncol. 29:862–866. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Kronberg U, Lopez-Kostner F, Soto G,
Zúñiga A, Wistuba I, Miranda V, Pinto E, Viviani P and Marshall G:
Detection of lymphatic micrometastases in patients with stage I and
II colorectal cancer: impact on five-year survival. Dis Colon
Rectum. 47:1151–1157. 2004.PubMed/NCBI
|
|
25.
|
Laso CA, Gonzalez JJ, Frenso F, Azcano E,
Sanz L and Navarrete F: Prognostic value of micrometastases in
esophageal and colorectal carcinoma: a clinical experience.
Hepatogastroenterology. 51:964–967. 2004.PubMed/NCBI
|
|
26.
|
Rosenberg R, Friederichs J, Gertler R,
Hoos A, Mueller J, Nahrig J, Nekarda H and Siewert JR: Prognostic
evaluation and review of immunohistochemically detected
disseminated tumor cells in peritumoral lymph nodes of patients
with pN0 colorectal cancer. Int J Colorectal Dis. 19:430–437. 2004.
View Article : Google Scholar
|
|
27.
|
Mukai M, Sato S, Ninomiya H, Wakui K,
Komatsu N, Tsuchiya K, Nakasaki H and Makuuchi H: Recurrence and
5-FU sensitivity of stage II/Dukes’ B colorectal cancer with occult
neoplastic cells in lymph node sinuses. Oncol Rep. 14:1171–1176.
2005.PubMed/NCBI
|
|
28.
|
Lee MR, Hong CW, Yoon SN, Lim SB, Park KJ,
Lee MJ, Kim WH and Park JG: Isolated tumor cells in lymph nodes are
not a prognostic marker for patients with stage I and stage II
colorectal cancer. J Surg Oncol. 93:13–18. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Garcia-Saenz JA, Saenz MC, Gonzalez L,
Pérez-Segura P, Puente J, López-Tarruella S, Sastre J, Casado A,
López-Asenjo JG and Díaz-Rubio E: Significance of the
immunohistochemical detection of lymph node micrometastases in
stage II colorectal carcinoma. Clin Transl Oncol. 8:676–680. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Messerini L, Cianchi F, Cortesini C and
Comin CE: Incidence and prognostic significance of occult tumor
cells in lymph nodes from patients with stage IIA colorectal
carcinoma. Hum Pathol. 37:1259–1267. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Wang C, Zhou ZG, Yu YY, Li Y, Lei WZ,
Cheng Z and Chen ZX: Patterns of lateral pelvic lymph node
metastases and micrometastases for patients with lower rectal
cancer. Eur J Surg Oncol. 33:463–467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Hara M, Hirai T, Nakanishi H, Kanemitsu Y,
Komori K, Tatematsu M and Kato T: Isolated tumor cell in lateral
lymph node has no influences on the prognosis of rectal cancer
patients. Int J Colorectal Dis. 22:911–917. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Fleming FJ, Hayanga AJ, Glynn F, Thakore
H, Kay E and Gillen P: Incidence and prognostic influence of lymph
node micrometastases in rectal cancer. Eur J Surg Oncol.
33:998–1002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Steinert R, Hantschick M, Vieth M,
Gastinger I, Kühnel F, Lippert H and Reymond MA: Influence of
subclinical tumor spreading on survival after curative surgery for
colorectal cancer. Arch Surg. 143:122–128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Davies M, Arumugam PJ, Shah VI, Watkins A,
Roger Morgan A, Carr ND and Beynon J: The clinical significance of
lymph node micrometastasis in stage I and stage II colorectal
cancer. Clin Transl Oncol. 10:175–179. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Park SJ, Lee KY and Kim SY: Clinical
significance of lymph node micrometastasis in stage I and stage II
colon cancer. Cancer Res Treat. 40:75–80. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Bosch-Roig CE, Rosello-Sastre E,
Alonso-Hemandez S, Almenar Cubells D, Grau Cardona E, Camarasa
Lillo N, Bautista D and Molins Palau C: Prognostic value of the
detection of lymph node micrometastases in colon cancer. Clin
Transl Oncol. 10:572–578. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Koyanagi K, Bilchik AJ, Saha S, Turner RR,
Wiese D, McCarter M, Shen P, Deacon L, Elashoff D and Hoon DS:
Prognostic relevance of occult nodal micrometastases and
circulating tumor cells in colorectal cancer on a prospective
multicenter trial. Clin Cancer Res. 14:7391–7396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Waldman SA, Hyslop T, Schulz S, Barkun A,
Nielsen K, Haaf J, Bonaccorso C, Li Y and Weinberg DS: Association
of GUCY2C expression in lymph nodes with time to recurrence and
disease-free survival in pN0 colorectal cancer. JAMA. 301:745–752.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
van Schaik PM, Hermans E, van der Linden
JC, Pruijt JR, Ernst MF and Bosscha K: Micro-metastases in stages I
and II colon cancer are a predictor of the development of distant
metastases and worse disease-free survival. Eur J Surg Oncol.
35:492–496. 2009.PubMed/NCBI
|
|
41.
|
Uribarrena-Amezaga R, Ortego J, Fuentes J,
Raventós N, Parra P and Uribarrena-Echevarría R: Prognostic value
of lymph node micrometastasis in patients with colorectal cancer in
Dukes stages A and B (T1-T4, N0, M0). Rev Esp Enferm Dig.
102:176–186. 2010.(In Spanish).
|
|
42.
|
Haince JF, Houde M, Beaudry G, L’espérance
S, Garon G, Desaulniers M, Hafer LJ, Heald JI, Lyle S, Grossman SR,
Têtu B, Sargent DJ and Fradet Y: Comparison of histopathology and
RT-qPCR amplification of guanylyl cyclase C for detection of colon
cancer metastases in lymph nodes. J Clin Pathol. 63:530–537. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Faerden AE, Sjo OH, Bukholm IR, Andersen
SN, Svindland A, Nesbakken A and Bakka A: Lymph node
micrometastases and isolated tumor cells influence survival in
stage I and II colon cancer. Dis Colon Rectum. 54:200–206. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Oh TY, Moon SM, Shin US, Lee HR and Park
SH: Impact of prognosis of lymph node micrometastasis and isolated
tumor cells in stage II colorectal cancer. J Korean Sc Coloproctol.
27:71–77. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Hyslop T, Weinberg DS, Schulz S, Barkun A
and Waldman SA: Occult tumor burden predicts disease recurrence in
lymph node-negative colorectal cancer. Clin Cancer Res.
17:3293–3303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Mescoli C, Albertoni L, Pucciarelli S,
Giacomelli L, Russo VM, Fassan M, Nitti D and Rugge M: Isolated
tumor cells in regional lymph nodes as relapse predictors in stage
I and II colorectal cancer. J Clin Oncol. 30:965–971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Guller U, Zajac P, Schnider A, Bösch B,
Vorburger S, Zuber M, Spagnoli GC, Oertli D, Maurer R, Metzger U,
Harder F, Heberer M and Marti WR: Disseminated single tumor cell as
detected by real-time quantitative polymerase chain reaction
represent a prognostic factor in patients undergoing surgery for
colorectal cancer. Ann Surg. 236:768–775. 2002. View Article : Google Scholar
|
|
48.
|
Yamamoto S, Akasu T, Fujita S and Moriya
Y: Long-term prognostic value of conventional peritoneal cytology
after curative resection for colorectal carcinoma. Jpn J Clin
Oncol. 33:33–37. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Kanellos I, Demetriades H, Zintzaras E,
Mandrali A, Mantzoros I and Betsis D: Incidence and prognostic
value of positive peritoneal cytology in colorectal cancer. Dis
Colon Rectum. 46:535–539. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Bosch B, Guller U, Schnider A, Maurer R,
Harder F, Metzger U and Marti WR: Perioperative detection of
disseminated tumour cells is an independent prognostic factor in
patients with colorectal cancer. Br J Surg. 90:882–888. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Baskaranathan S, Philips J, McCredden P
and Solomon MJ: Free colorectal cancer cells on the peritoneal
surface: correlation with pathologic variables and survival. Dis
Colon Rectum. 47:2076–2079. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Lloyd JM, McIver CM, Stephenson SA, Hewett
PJ, Rieger N and Hardingham JE: Identification of early-stage
colorectal cancer patients at risk of relapse post-resection by
immunobead reverse transcription-PCR analysis of peritoneal lavage
fluid for malignant cells. Clin Cancer Res. 12:417–423. 2006.
View Article : Google Scholar
|
|
53.
|
Kanellos I, Zacharakis E, Kanellos D,
Pramateftakis MG and Betsis D: Prognostic significance of CEA level
and positive cytology in peritoneal washings in patients with
colorectal cancer. Colorectal Dis. 8:436–440. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Gozalan U, Yasti AC, Yuksek YN, Reis E and
Kama NA: Peritoneal cytology in colorectal cancer: incidence and
prognostic value. Am J Surg. 193:672–675. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Katoh H, Yamashita K, Sato T, Ozawa H,
Nakamura T and Watanabe M: Prognostic significance of peritoneal
tumour cells identified at surgery for colorectal cancer. Br J
Surg. 96:769–777. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
56.
|
Noura S, Ohue M, Seki Y, Yano M, Ishikawa
O and Kameyama M: Long-term prognostic value of conventional
peritoneal lavage cytology in patients undergoing curative
colorectal cancer resection. Dis Colon Rectum. 52:1312–1220. 2009.
View Article : Google Scholar
|
|
57.
|
Nishikawa T, Watanabe T, Sunami E, Tsuno
NH, Kitayama J and Nagawa H: Prognostic value of peritoneal
cytology and the combination of peritoneal cytology and peritoneal
dissemination in colorectal cancer. Dis Colon Rectum. 52:2016–2021.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Temesi R, Sikorszki L, Bezsilla J, Botos
A, Kovács J and Tihanyi T: Impact of intraabdominal lavage cytology
on the long-term prognosis of colorectal cancer patients. World J
Surg. 36:2714–2721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Bessa X, Pinol V, Castellvi-Bel S,
Piazuelo E, Lacy AM, Elizalde JI, Piqué JM and Castells A:
Prognostic value of postoperative detection of blood circulating
tumor cells in patients with colorectal cancer operated for cure.
Ann Surg. 237:368–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Giacomelli L, Gianni W, Belfiore C,
Gandini O, Repetto L, Filippini A, Frati L, Aglianò AM and
Gazzaniga P: Persistence of epidermal growth factor receptor and
interleukin 10 in blood of colorectal cancer patients after surgery
identifies patients with high risk of relapse. Clin Cancer Res.
9:2678–2682. 2003.
|
|
61.
|
Chen WS, Chung MY, Liu JH, Liu JM and Lin
JK: Impact of circulating free tumor cells in the peripheral blood
of colorectal cancer patients during laparoscopic surgery. World J
Surg. 28:552–557. 2004.PubMed/NCBI
|
|
62.
|
Zhang XW, Yang HY, Fan P, Yang L and Chen
GY: Detection of micrometastasis in peripheral blood by
multi-sampling in patients with colorectal cancer. World J
Gastroenterol. 11:436–438. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Sadahiro S, Suzuki T, Ishikawa K, Saguchi
T, Maeda Y, Yasuda S, Makuuchi H, Yurimoto S and Murayama C:
Detection of carcinoembryonic antigen messenger RNA-expressing
cells in portal and peripheral blood during surgery does not
influence relapse in colorectal cancer. Ann Surg Oncol. 12:988–994.
2005. View Article : Google Scholar
|
|
64.
|
Douard R, Wind P, Sales JP, Landi B,
Berger A, Benichou J, Gayral F, Loric S and Cugnenc PH: Long-term
prognostic value of detection of circulating colorectal cancer
cells using CGM2 reverse transcription-polymerase chain reaction
assay. Surgery. 139:556–562. 2006. View Article : Google Scholar
|
|
65.
|
Iinuma H, Okinaga K, Egami H, Mimori K,
Hayashi N, Nishida K, Adachi M, Mori M and Sasako M: Usefulness and
clinical significance of quantitative real-time RT-PCR to detect
isolated tumor cells in the peripheral blood and tumor drainage
blood of patients with colorectal cancer. Int J Oncol. 28:297–306.
2006.PubMed/NCBI
|
|
66.
|
Koch M, Kienle P, Kastrati D, Antolovic D,
Schmidt J, Herfarth C, von Knebel Doeberitz M and Weitz J:
Prognostic impact of hematogenous tumor cell dissemination in
patients with stage II colorectal cancer. Int J Cancer.
118:3072–3077. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67.
|
Katsumata K, Sumi T, Mori Y, Hisada M,
Tsuchida A and Aoki T: Detection and evaluation of epithelial cells
in the blood of colon cancer patients using RT-PCR. Int J Clin
Oncol. 11:385–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
68.
|
Allen-Mersh TG, McCullough TK, Patel H,
Wharton RQ, Glover C and Jonas SK: Role of circulating tumour cells
in predicting recurrence after excision of primary colorectal
carcinoma. Br J Surg. 94:96–105. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
69.
|
Sadahiro S, Suzuki T, Maeda Y, Yurimoto S,
Yasuda S, Makuuchi H, Kamijo A and Murayama C: Detection of
carcinoembryonic antigen messenger RNA-expressing cells in
peripheral blood 7 days after curative surgery is a novel
prognostic factor in colorectal cancer. Ann Surg Oncol.
14:1092–1098. 2007. View Article : Google Scholar
|
|
70.
|
Koch M, Antolovic D, Kienle P, Horstmann
J, Herfarth C, von Knebel Doeberitz M and Weitz J: Increased
detection rate and potential prognostic impact of disseminated
tumor cells in patients undergoing endorectal ultrasound for rectal
cancer. Int J Colorectal Dis. 22:359–365. 2007. View Article : Google Scholar
|
|
71.
|
Wang JY, Lin SR, Wu DC, Lu CY, Yu FJ,
Hsieh JS, Cheng TL, Koay LB and Uen YH: Multiple molecular markers
as predictors of colorectal cancer in patients with normal
perioperative serum carcinoembryonic antigen levels. Clin Cancer
Res. 13:2406–2413. 2007. View Article : Google Scholar
|
|
72.
|
Friederichs J, Gertler R, Rosenberg R,
Dahm M, Nekarda H, Holzmann B and Siewert JR: Correlation of
CK20-positive cells in peripheral venous blood with serum CEA
levels in patients with colorectal carcinoma. World J Surg.
31:2329–2334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
73.
|
Uen YH, Lin SR, Wu DC, Su YC, Wu JY, Cheng
TL, Chi CW and Wang JY: Prognostic significance of multiple
molecular markers for patients with stage II colorectal cancer
undergoing curative resection. Ann Surg. 246:1040–1046. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
74.
|
Uen YH, Lu CY, Tsai HL, Yu FJ, Huang MY,
Cheng TL, Lin SR and Wang JY: Persistent presence of postoperative
circulating tumor cells is a poor prognostic factor for patients
with stage I–III colorectal cancer after curative resection. Ann
Surg Oncol. 15:2120–2128. 2008.PubMed/NCBI
|
|
75.
|
Yie SM, Lou B, Ye SR, Cao M, He X, Li P,
Hu K, Rao L, Wu SM, Xiao HB and Gao E: Detection of
surviving-expressing circulating cancer cells (CCCs) in peripheral
blood of patients with gastric and colorectal cancer reveals high
risks of relapse. Ann Surg Oncol. 15:3073–3082. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
76.
|
Wong SC, Chan CM, Ma BB, Hui EP, Ng SS,
Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC and Chan AT:
Clinical significance of cytokeratin 20-positive circulating tumor
cells detected by a refined immunomagnetic enrichment assay in
colorectal cancer patients. Clin Cancer Res. 15:1005–1012. 2009.
View Article : Google Scholar
|
|
77.
|
Vardakis N, Messaritakis I, Papadaki C,
Agoglossakis G, Sfakianaki M, Saridaki Z, Apostolaki S,
Koutroubakis I, Perraki M, Hatzidaki D, Mavroudis D, Georgoulias V
and Souglakos J: Prognostic significance of the detection of
peripheral blood CEACAM5 mRNA-positive cells by real-time
polymerase chain reaction in operable colorectal cancer. Clin
Cancer Res. 17:165–173. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
78.
|
Lu CY, Uen YH, Tsai HL, Chuang SC, Hou MF,
Wu DC, Juo SH, Lin SR and Wang JY: Molecular detection of
persistent postoperative circulating tumour cells in stages II and
III colon cancer patients via multiple blood sampling: prognostic
significance of detection for early relapse. Br J Cancer.
104:1178–1184. 2011. View Article : Google Scholar
|
|
79.
|
Iinuma H, Watanabe T, Mimori K, Adachi M,
Hayashi N, Tamura J, Matsuda K, Fukushima R, Okinaga K, Sasako M
and Mori M: Clinical significance of circulating tumor cells,
including cancer stem-like cells, in peripheral blood for
recurrence and prognosis in patients with Dukes’ stage B and C
colorectal cancer. J Clin Oncol. 29:1547–1555. 2011.PubMed/NCBI
|
|
80.
|
Sunouchi K, Machinami R, Mori M, Namiki K,
Hattori S, Murata Y, Tsuchiya T, Mizuno H and Tadokoro M: Clinical
impact of carcinoembryonic antigen messenger ribonucleic acid
expression in tumor-draining vein blood on postoperative liver
metastasis in patients with colorectal carcinoma: a prospective,
cohort study. Dis Colon Rectum. 46:467–473. 2003. View Article : Google Scholar
|
|
81.
|
Akashi A, Komuta K, Haraguchi M, Ueda T,
Okudaira S, Furui J and Kanematsu T: Carcinoembryonic antigen mRNA
in the mesenteric vein is not a predictor of hepatic metastasis in
patients with resectable colorectal cancer: a long-term study. Dis
Colon Rectum. 46:1653–1658. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
82.
|
Kanellos I, Zacharakis E, Kanellos D,
Pramateftakis MG, Tsahalis T, Altsitsiadis E and Betsis D:
Prognostic significance of CEA levels and detection of CEA mRNA in
draining venous blood in patients with colorectal cancer. J Surg
Oncol. 94:3–8. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
83.
|
Shimada R, Iinuma H, Akahane T, Horiuchi A
and Watanabe T: Prognostic significance of CTCs and CSCs of tumor
drainage vein blood in Dukes’ stage B and C colorectal cancer
patients. Oncol Rep. 27:947–953. 2012.PubMed/NCBI
|
|
84.
|
O’Connor OJ, Cahill RA, Kirwan WO and
Redmond HP: The impact of bone marrow micrometastases on metastatic
disease-free survival in patients with colorectal carcinoma.
Colorectal Dis. 7:406–409. 2005.PubMed/NCBI
|
|
85.
|
Flatmark K, Borgen E, Nesland JM,
Rasmussen H, Johannessen HO, Bukholm I, Rosales R, Hårklau L,
Jacobsen HJ, Sandstad B, Boye K and Fodstad Ø: Disseminated tumour
cells as a prognostic biomarker in colorectal cancer. Br J Cancer.
104:1434–1439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
86.
|
Vlems FA, Diepstra JH, Punt CJ, Ligtenberg
MJ, Cornelissen IM, van Krieken JH, Wobbes T, van Muijen GN and
Ruers TJ: Detection of disseminated tumour cells in blood and bone
marrow samples of patients undergoing hepatic resection for
metastasis of colorectal cancer. Br J Surg. 90:989–995. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
87.
|
Fruhauf NR, Kasimir-Bauer S, Gorlinger K,
Lang H, Kaudel CP, Kaiser GM, Oldhafer KJ and Broelsch CE:
Peri-operative filtration of disseminated cytokeratin positive
cells in patients with colorectal liver metastasis. Langenbecks
Arch Surg. 390:15–20. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88.
|
Koch M, Kienle P, Hinz U, Antolovic D,
Schmidt J, Herfarth C, von Knebel Doeberitz M and Weitz J:
Detection of hematogenous tumor cell dissemination predicts tumor
relapse in patients undergoing surgical resection of colorectal
liver metastases. Ann Surg. 241:199–205. 2005. View Article : Google Scholar
|
|
89.
|
Topal B, Aerts JL, Roskams T, Fieuws S,
Van Pelt J, Vandekerckhove P and Penninckx F: Cancer cell
dissemination during curative surgery for colorectal liver
metastases. Eur J Surg Oncol. 31:506–511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
90.
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC,
Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Relationship of
circulating tumor cells to tumor response, progression-free
survival, and overall survival in patients with metastatic
colorectal cancer. J Clin Oncol. 26:3213–3221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
91.
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse MA, Mitchell E, Miller MC,
Doyle GV, Tissing H, Terstappen LW and Meropol NJ: Prognostic
significance of circulating tumor cells in patients with metastatic
colorectal cancer. Ann Oncol. 20:1223–1229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
92.
|
Tol J, Koopman M, Miller MC, Tibbe A, Cats
A, Creemers GJ, Vos AH, Nagtegaal ID, Terstappen LW and Punt CJ:
Circulating tumor cells early predict progression-free and overall
survival in advanced colorectal cancer patients treated with
chemotherapy and targeted agents. Ann Oncol. 21:1006–1012. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
93.
|
Rahbari NN, Reissfelder C, Muhlbayer M,
Weidmann K, Kahlert C, Büchler MW, Weitz J and Koch M: Correlation
of angiogenic factors with circulating tumor cells and disease
recurrence in patients undergoing curative resection for colorectal
liver metastases. Ann Surg Oncol. 18:2182–2191. 2011. View Article : Google Scholar
|
|
94.
|
Pilati P, Mocellin S, Bertazza L, Galdi F,
Briarava M, Mammano E, Tessari E, Zavagno G and Nitti D: Prognostic
value of putative circulating cancer stem cells in patients
undergoing hepatic resection for colorectal liver metastasis. Ann
Surg Oncol. 19:402–408. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
95.
|
Bjørnland K, Flatmark K, Mala T, Mathisen
O, Bakka A, Aasen AO, Bergan A, Søreide O and Fodstad O: Detection
of disseminated tumour cells in bone marrow of patients with
isolated liver metastases from colorectal cancer. J Surg Oncol.
82:224–227. 2003.PubMed/NCBI
|
|
96.
|
Schoppmeyer K, Fruhauf N, Oldhafer K,
Seeber S and Kasimir-Bauer S: Tumor cell dissemination in colon
cancer does not predict extrahepatic recurrence in patients
undergoing surgery for hepatic metastases. Oncol Rep. 15:449–454.
2006.PubMed/NCBI
|
|
97.
|
Vogelaar FJ, Mesker WE, Rijken AM, van
Pelt GW, van Leeuwen AM, Tanke HJ, Tollenaar RA and Liefers GJ:
Clinical impact of different detection methods for disseminated
tumor cells in bone marrow of patients undergoing surgical
resection of colorectal liver metastases: a prospective follow-up
study. BMC Cancer. 10:1532010. View Article : Google Scholar
|
|
98.
|
Buxhofer-Ausch V, Ausch C, Kitzweger E,
Mollik M, Reiner-Concin A, Ogris E, Stampfl M, Hamilton G,
Schiessel R and Hinterberger W: Spontaneous changes in tumour cell
dissemination to bone marrow in colorectal cancer. Colorectal Dis.
12:776–782. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
99.
|
Hinz S, Bockholst J, Roder C, Egberts JH,
Schafmayer C, Küchler T, Becker T and Kalthoff H: Disseminated
tumor cells in the bone marrow negatively influence survival after
resection of colorectal liver metastases. Ann Surg Oncol.
19:2539–2546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
100.
|
Yokoyama N, Shirai Y, Ajioka Y, Nagakura
S, Suda T and Hatakeyama K: Immunohistochemically detected hepatic
micrometastases predict a high risk of intrahepatic recurrence
after resection of colorectal carcinoma liver metastases. Cancer.
94:1642–1647. 2002. View Article : Google Scholar
|
|
101.
|
Schimanski CC, Linnemann U, Galle PR,
Arbogast R and Berger MR: Hepatic disseminated tumor cells in
colorectal cancer UICC stage IV patients: Prognostic implications.
Int J Oncol. 23:791–796. 2003.PubMed/NCBI
|
|
102.
|
Linnemann U, Schimanski CC, Gebhardt C and
Berger MR: Prognostic value of disseminated colorectal tumor cells
in the liver: results from follow-up examinations. Int J Colorectal
Dis. 19:380–386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
103.
|
Koch M, Kienle P, Logan E, Antolovic D,
Galindo L, Schmitz-Winnenthal FH, Schmidt J, Herfarth C and Weitz
J: Detection of disseminated tumor cells in liver biopsies of
colorectal cancer patients is not associated with a worse
prognosis. Ann Surg Oncol. 14:810–817. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
104.
|
Rahbari NN, Bork U, Motschall E, Thorlund
K, Büchler MW, Koch M and Weitz J: Molecular detection of tumor
cells in regional lymph nodes is associated with disease recurrence
and poor survival in node-negative colorectal cancer: a systematic
review and meta-analysis. J Clin Oncol. 30:60–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
105.
|
Braun S, Vogl FD, Naume B, Janni W,
Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G,
Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G,
Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A and Pantel K:
A pooled analysis of bone marrow micrometastasis in breast cancer.
N Engl J Med. 353:793–802. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
106.
|
Rahbari NN, Aigner M, Thorlund K, Mollberg
N, Motschall E, Jensen K, Diener MK, Büchler MW, Koch M and Weitz
J: Meta-analysis shows that detection of circulating tumor cells
indicates poor prognosis in patients with colorectal cancer.
Gastroenterology. 138:1714–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
107.
|
Peach G, Kim C, Zacharakis E, Purkayastha
S and Ziprin P: Prognostic significance of circulating tumor cells
following surgical resection of colorectal cancers: a systematic
review. Br J Cancer. 102:1327–1334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
108.
|
Allard WJ, Matera J, Miller MC, Repollet
M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor
cells circulate in the peripheral blood of all major carcinomas but
not in healthy subjects or patients with nonmalignant diseases.
Clin Cancer Res. 10:6897–6904. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
109.
|
Budd GT, Cristofanilli M, Ellis MJ,
Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV,
Terstappen LW and Hayes DF: Circulating tumor cells versus imaging
- predicting overall survival in metastatic breast cancer. Clin
Cancer Res. 12:6403–6409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
110.
|
Hayes DF, Cristofanilli M, Budd GT, Ellis
MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and
Terstappen LW: Circulating tumor cells at each follow-up time point
during therapy of metastatic breast cancer patients predict
progression-free and overall survival. Clin Cancer Res.
12:4218–4224. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
111.
|
Riethdorf S, Fritsche H, Muller V, Rau T,
Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson
S, Gornet T, Cristofanilli M and Pantel K: Detection of circulating
tumor cells in peripheral blood of patients with metastatic breast
cancer: a validation study of the CellSearch System. Clin Cancer
Res. 13:920–928. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
112.
|
Naoe M, Ogawa Y, Morita J, Omori K,
Takeshita K, Shichijyo T, Okumura T, Igarashi A, Yanaihara A,
Iwamoto S, Fukagai T, Miyazaki A and Yoshida H: Detection of
circulating urothelial cancer cells in the blood using the
CellSearch System. Cancer. 109:1439–1445. 2007. View Article : Google Scholar : PubMed/NCBI
|
